☰

Cheol Moon, Ph.D. - Publications

Affiliations: 
2007 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Nguyen TV, Lee KH, Huang Y, Shin MC, Park YS, Kim H, Moon C. Topical Delivery of Cell-Penetrating Peptide-Modified Human Growth Hormone for Enhanced Wound Healing. Pharmaceuticals (Basel, Switzerland). 16. PMID 36986493 DOI: 10.3390/ph16030394  0.387
2020 Park T, Lee S, Amatya R, Cheong H, Moon C, Kwak HD, Min KA, Shin MC. ICG-Loaded PEGylated BSA-Silver Nanoparticles for Effective Photothermal Cancer Therapy. International Journal of Nanomedicine. 15: 5459-5471. PMID 32801700 DOI: 10.2147/Ijn.S255874  0.321
2020 Amatya R, Park T, Hwang S, Yang J, Lee Y, Cheong H, Moon C, Kwak HD, Min KA, Shin MC. Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides. Toxins. 12. PMID 32397648 DOI: 10.3390/Toxins12050313  0.416
2019 Oh E, Kim U, Lee BJ, Moon C. Multivariate Statistical Optimization of Tablet Formulations Incorporating High Doses of a Dry Herbal Extract. Pharmaceutics. 11. PMID 30781880 DOI: 10.3390/Pharmaceutics11020079  0.332
2018 Park T, Min KA, Cheong H, Moon C, Shin MC. Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy. Journal of Drug Targeting. 1-33. PMID 30156929 DOI: 10.1080/1061186X.2018.1516221  0.432
2018 Song H, Moon C, Lee BJ, Oh E. Mesoporous pravastatin solid dispersion granules incorporable into orally disintegrating tablets. Journal of Pharmaceutical Sciences. PMID 29530714 DOI: 10.1016/J.Xphs.2018.03.003  0.322
2018 Maharjan P, Cho KH, Maharjan A, Shin MC, Moon C, Min KA. Pharmaceutical challenges and perspectives in developing ophthalmic drug formulations Journal of Pharmaceutical Investigation. 49: 215-228. DOI: 10.1007/S40005-018-0404-6  0.356
2017 Wang H, Moon C, Shin MC, Wang Y, He H, Yang VC, Huang Y. Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy. Nanotheranostics. 1: 114-130. PMID 29071181 DOI: 10.7150/ntno.18292  0.604
2017 Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC. Tandem-Multimeric F3-Gelonin Fusion Toxins for Enhanced Anti-Cancer Activity for Prostate Cancer Treatment. International Journal of Pharmaceutics. PMID 28359823 DOI: 10.1016/J.Ijpharm.2017.03.072  0.595
2017 Van Nguyen T, Shin MC, Min KA, Huang Y, Oh E, Moon C. Cell-penetrating peptide-based non-invasive topical delivery systems Journal of Pharmaceutical Investigation. 48: 77-87. DOI: 10.1007/S40005-017-0373-1  0.458
2016 Lin T, Liu E, He H, Shin MC, Moon C, Yang VC, Huang Y. Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides. Acta Pharmaceutica Sinica. B. 6: 352-8. PMID 27471676 DOI: 10.1016/J.Apsb.2016.04.001  0.539
2016 Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity. Pharmaceutical Research. PMID 27251414 DOI: 10.1007/S11095-016-1959-4  0.56
2016 Jang DJ, Moon C, Oh E. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 80: 162-72. PMID 27133053 DOI: 10.1016/J.Biopha.2016.03.018  0.409
2016 Moon C, Oh E. Rationale and strategies for formulation development of oral fixed dose combination drug products Journal of Pharmaceutical Investigation. 46: 615-631. DOI: 10.1007/S40005-016-0286-4  0.374
2016 Kim S, Gupta B, Moon C, Oh E, Jeong JH, Yong CS, Kim JO. Employing an optimized spray-drying process to produce ezetimibe tablets with an improved dissolution profile Journal of Pharmaceutical Investigation. 46: 583-592. DOI: 10.1007/S40005-016-0277-5  0.303
2015 Yang Y, Park SY, Nguyen TT, Yu YH, Nguyen TV, Sun EG, Udeni J, Jeong MH, Pereira I, Moon C, Ha HH, Kim KK, Hur JS, Kim H. Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility. Plos One. 10: e0137889. PMID 26371759 DOI: 10.1371/Journal.Pone.0137889  0.326
2015 Truong DH, Tran TH, Ramasamy T, Choi JY, Lee HH, Moon C, Choi HG, Yong CS, Kim JO. Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib. Aaps Pharmscitech. PMID 26238806 DOI: 10.1208/S12249-015-0370-5  0.32
2014 Nguyen TT, Yoon S, Yang Y, Lee HB, Oh S, Jeong MH, Kim JJ, Yee ST, Cri?an F, Moon C, Lee KY, Kim KK, Hur JS, Kim H. Lichen secondary metabolites in Flavocetraria cucullata exhibit anti-cancer effects on human cancer cells through the induction of apoptosis and suppression of tumorigenic potentials. Plos One. 9: e111575. PMID 25360754 DOI: 10.1371/Journal.Pone.0111575  0.341
2014 Shin MC, Zhang J, Min KA, Lee K, Moon C, Balthasar JP, Yang VC. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 194: 197-210. PMID 25204286 DOI: 10.1016/J.Jconrel.2014.08.030  0.621
2014 Tan J, Cheong H, Park YS, Kim H, Zhang M, Moon C, Huang Y. Cell-penetrating peptide-mediated topical delivery of biomacromolecular drugs. Current Pharmaceutical Biotechnology. 15: 231-9. PMID 24938894 DOI: 10.2174/1389201015666140617094320  0.461
2014 Kim KH, Cho SA, Lim JY, Lim DG, Moon C, Jeong SH. Preparation of microcapsules with the evaluation of physicochemical properties and molecular interaction. Archives of Pharmacal Research. 37: 1570-7. PMID 24338504 DOI: 10.1007/S12272-013-0306-0  0.361
2012 David AE, Gong J, Chertok B, Domszy RC, Moon C, Park YS, Wang NS, Yang AJ, Yang VC. Immobilized thermolysin for highly efficient production of low-molecular-weight protamine--an attractive cell-penetrating peptide for macromolecular drug delivery applications. Journal of Biomedical Materials Research. Part A. 100: 211-9. PMID 22042599 DOI: 10.1002/Jbm.A.33244  0.676
2012 Subedi RK, Ryoo J, Moon C, Chun M, Choi H. Formulation and in vitro evaluation of transdermal drug delivery system for donepezil Journal of Pharmaceutical Investigation. 42: 1-7. DOI: 10.1007/S40005-012-0002-Y  0.351
2011 Subedi RK, Ryoo JP, Moon C, Choi HK. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. International Journal of Pharmaceutics. 419: 209-14. PMID 21843607 DOI: 10.1016/J.Ijpharm.2011.08.002  0.333
2010 Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery. Current Pharmaceutical Design. 16: 2369-76. PMID 20618157 DOI: 10.2174/138161210791920441  0.638
2010 Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Synthetic skin-permeable proteins enabling needleless immunization. Angewandte Chemie (International Ed. in English). 49: 2724-7. PMID 20232417 DOI: 10.1002/Anie.200906153  0.571
2009 Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). Journal of Controlled Release : Official Journal of the Controlled Release Society. 139: 182-9. PMID 19577600 DOI: 10.1016/J.Jconrel.2009.06.027  0.545
2008 Moon C, Kwon YM, Lee WK, Park YJ, Chang LC, Yang VC. A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation. Journal of Biomedical Materials Research. Part A. 84: 238-46. PMID 17607767 DOI: 10.1002/Jbm.A.31452  0.688
2007 Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 124: 43-50. PMID 17904680 DOI: 10.1016/J.Jconrel.2007.08.029  0.627
2005 Park YJ, Chang LC, Liang JF, Moon C, Chung CP, Yang VC. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1555-7. PMID 16033808 DOI: 10.1096/Fj.04-2322Fje  0.687
Show low-probability matches.